Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia — StellaPhase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(6 sites)
Germany
University Hospital of Würzburg, med. Poliklinik, Würzburg Netherlands
Erasmus Universität Medisch Centrum Rotterdam, Department of Internal Medicine, Rotterdam Switzerland
Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Canton of Vaud University Hospital Basel, Basel Kantonsspital Luzern, Lucerne Age range
18 Years and older
Last updated November 2025